We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+23.2%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$75M
Cap. Flow
+$46.3M
Cap. Flow %
14.89%
Top 10 Hldgs %
18.62%
Holding
1,633
New
628
Increased
240
Reduced
242
Closed
312

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.5M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$3.75M
3
UNH icon
UnitedHealth
UNH
+$3.2M
4
FCRS.U
FutureCrest Acquisition Corp Units
FCRS.U
+$2.72M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.71M

Top Sells

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$5.26M
2
VOD icon
Vodafone
VOD
+$5.12M
3
ERIC icon
Ericsson
ERIC
+$4.88M
4
JNPR
Juniper Networks
JNPR
+$4.21M
5
CCIR
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
+$3.45M

Sector Composition

Rank Sector Weight
1 Technology 25.26%
2 Healthcare 12.39%
3 Financials 11.37%
4 Consumer Discretionary 7.84%
5 Industrials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARCB icon
1201
ArcBest
ARCB
$3.14B
– –
-670
Closed -$51K
ASO icon
1202
Academy Sports + Outdoors
ASO
$3.05B
$0 ﹤0.01%
+14
New +$715
ASTE icon
1203
Astec Industries
ASTE
$994M
– –
-668
Closed -$27K
ATI icon
1204
ATI
ATI
$31.4B
– –
-100
Closed -$8K
AVNW icon
1205
Aviat Networks
AVNW
$282M
– –
-7,070
Closed -$170K
AXON
1206
Axon Enterprise
AXON
$48.7B
– –
-650
Closed -$538K
AXP icon
1207
American Express
AXP
$232B
– –
-4,000
Closed -$1.27M
AYTU icon
1208
AYTU BioPharma
AYTU
$25.3M
$0 ﹤0.01%
130
-35,791
-100% -$82.7K
BA icon
1209
CALL
Boeing
BA
$183B
– –
-36
Closed -$7K
BA icon
1210
PUT
Boeing
BA
$183B
– –
-87
Closed -$18K
BANC icon
1211
Banc of California
BANC
$3.1B
$0 ﹤0.01%
50
– –
BASE
1212
DELISTED
Couchbase
BASE
– –
-5,500
Closed -$134K
BASE
1213
PUT
DELISTED
Couchbase
BASE
– –
-57
Closed -$1K
BB icon
1214
BlackBerry
BB
$5.14B
$0 ﹤0.01%
1
– –
BBAI icon
1215
BigBear.ai
BBAI
$1.56B
$0 ﹤0.01%
14
-3,552
-100% -$22.7K
BBIO icon
1216
BridgeBio Pharma
BBIO
$16.4B
– –
-3,500
Closed -$151K
BC icon
1217
Brunswick
BC
$5.21B
– –
-1,480
Closed -$81K
BCTX
1218
Briacell Therapeutics
BCTX
$29.7M
$0 ﹤0.01%
10
– –
BEKE icon
1219
KE Holdings
BEKE
$19.2B
$0 ﹤0.01%
+14
New +$262
BGSF icon
1220
BGSF Inc
BGSF
$57.6M
– –
-8,000
Closed -$50K
BIRK icon
1221
Birkenstock
BIRK
$6.76B
– –
-335
Closed -$16K
BNY
1222
Bank of New York Mellon
BNY
$111B
– –
-13
Closed -$1K
BMEZ icon
1223
BlackRock Health Sciences Trust II
BMEZ
$1.01B
– –
-1,200
Closed -$17K
BMR icon
1224
Beamr Imaging
BMR
$20.3M
– –
-1,002
Closed -$3K
BP icon
1225
BP
BP
$111B
– –
-75,800
Closed -$2.27M
47 48
49
50 51

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
CCC
Compass Capital Corp Braintree, Massachusetts $279M AUM 28.36% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return

FNY Investment Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, FNY Investment Advisers held 1,633 positions worth $311M, up 32% from $236M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

FNY Investment Advisers deployed $46.3M of net new capital in Q3 2025, opening 628 new positions and adding to 240 existing holdings. Its largest new stake was Verona Pharma: 148,120 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ramaco Resources Class A, an estimated $3.39M trimmed.

  • FNY Investment Advisers's largest Q3 2025 buy was Verona Pharma: 148,120 shares worth $15.8M.
  • FNY Investment Advisers added most to UnitedHealth in Q3 2025, an estimated $3.2M increase.
  • FNY Investment Advisers's biggest Q3 2025 reduction was Ramaco Resources Class A, cutting an estimated $3.39M.
  • FNY Investment Advisers fully exited Blueprint Medicines in Q3 2025, selling an estimated $5.26M.
  • FNY Investment Advisers's ten largest holdings make up 19% of its $311M portfolio in Q3 2025.
  • FNY Investment Advisers opened 628 new positions and closed 312 in Q3 2025.
  • FNY Investment Advisers's portfolio value rose 32% quarter-over-quarter to $311M.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.